Business Context and Reporting Period
Company: Nano Labs Ltd
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: October 11, 2024
Reporting Period: Month of October 2024
Context: This filing incorporates by reference a press release (Exhibit 99.1) regarding the resolution of a deficiency related to the Nasdaq Minimum Market Value of Publicly Held Shares requirement.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a procedural update to incorporate a press release rather than a financial statement.
Material Changes
- Regulatory Status: Nano Labs Ltd has resolved the deficiency concerning the Minimum Market Value of Publicly Held Shares on Nasdaq.
- Registration Update: The incorporated press release becomes part of the Company's Registration Statement on Form F-3 (Registration No. 333-273968) filed on August 14, 2023.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, or specific risk factors beyond the resolution of the Nasdaq listing deficiency. No unusual items or contingencies are detailed in the provided text.
Investor Verification Checklist
- Verify the full text of Exhibit 99.1 (Press Release) to confirm the specific details of the Nasdaq deficiency resolution.
- Confirm the current status of the Company's shares on Nasdaq following this resolution.
- Review the Form F-3 Registration Statement (No. 333-273968) to understand how this press release impacts the offering.